Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.
The U.S. Food and Drug Administration (FDA) is holding a virtual meeting on April 6 to discuss future COVID-19 boosters, announced on Monday.
The Federal Register will publish within days the Labor Department's rule requiring private businesses with 100 or more employees to vaccinate them or test them weekly, fulfilling an announcement President Joe Biden made in September.
The shot will combine Moderna's current COVID-19 vaccine with a new flu vaccine that is still under development.
Moderna's COVID-19 vaccine could become second to win full approval following Pfizer/BioNTech.
At random, two kids will be assigned to get the Pfizer vaccine for every one child who gets a placebo.
On its last day, more than 220 appointments were scheduled.
Results indicated a 90% drop in infection risk after participants were fully vaccinated, or in other words, two weeks after they received second jabs developed by Pfizer or Moderna.
Churchill Downs teamed up with Norton Healthcare to host a three-day vaccine clinic.
Out of the 1,296 Jefferson County residents who participated, 91% of them would choose to get the vaccine, according to a news release.